About this Course
Pharmacists possess the training and skills necessary to administer certain long-acting injectable (LAI) medications used in the management of mental illnesses and substance use disorders. Through collaborative practice agreements, pharmacists can administer Long Acting Injectables in almost every state. In some states, including the state of Connecticut, this occurs via collaborative agreements, and necessary injection and disease state training. Administration of these medications by pharmacists can increase accessibility of care for patients.
UConn has developed web-based and LIVE continuing pharmacy education activities to enhance pharmacists’ skills and help them make sound clinical decisions about long acting injectables administration. This course includes eight hours of CPE (or eight hours of credit), required by the State of Connecticut. Successful completion of these eight hours (with five activities consisting of three hours online pre-requisite work, two hours of LIVE Law CE and three hours of hands-on LAIA training) will earn the pharmacist a Certificate in Long-Acting Injectables of Psychotropic Medication.
The LIVE Workshop listed below is required to earn the Long-Acting Injectable Psychotropic Medication Pharmacist certificate. The Workshop consists of 2 hours of Live Law CE-Collaborative Practice Agreement & Documentation Best Practices and 3 hours of Hands-on training-Long Acting Injectables Hands-On LIVE Workshop.
The Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program costs $299 and includes both the 3 online prerequisites and this full day of LIVE training.
Friday, March 20, 2026
8:00 am - 4:00 pm
Pharmacy Biology Building-Room 229
Storrs, CT
A light breakfast and lunch will be served.
Target Audience
Pharmacists who are interested in administering long acting injectable psychotropic medications to their patients.
This activity is NOT accredited for technicians.
Pharmacist Learning Objectives
At the end of this application and practice-based continuing education activity, the learner will be able to:
| Describe the impact of stigma within the healthcare system and utilize non-stigmatizing terminology when talking to and about patients with psychiatric and/or substance use disorders |
| Identify patient barriers to obtaining appropriate treatment for psychiatric and/or substance use disorders |
| Explain the potential impact of LAI medications on patient health outcomes |
| Identify the key components of the Collaborative Practice Agreement associated with LAI medications |
| Describe the key components of the Notes on Injection Clinical Encounter (NICE) documentation form |
| Apply different best practices for documentation, maintenance of files, and communications with prescribers |
| Describe the steps in the safe and effective use of different LAI medications for schizophrenia, bipolar disorder, and substance use disorder |
| Compare and contrast how the administration techniques are similar or different for the different LAI medications |
| Demonstrate the use sterile injection techniques and best practices in the administration of different LAI products |
Release Date
Released: 1/31/2024
Expires: 1/31/2027
Course Fee
$299
ACPE UANs
0009-0000-24-012-L03-P
0009-0000-24-013-L01-P
Accreditation Hours
5.0 hours of LIVE CE
Bundle Deal
You may register for individual online topics at $17/CE Credit Hour if you are not interested in attending the live workshop.
If desired, pharmacists can register for the entire Long-Acting Injectable Psychotropic Medication Pharmacist Certificate Training Program. The Certificate consists of 3 prerequisite activities in our online catalog (included in registration), 2 hours of LIVE Law CE, and 3 hours of hands-on training in-person activities that comprise the 5 hour LIVE workshop at $299.00.
To attend the live training, you must register for only LAIA 2026 LIVE Certificate Training. The prerequisites are already included in this bundled pricing of $299.00
Accreditation Statement
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit will be issued for 5.0 hours (or 0.5 CEUS). Two hours (0.2 CEUs) of live Law CE-Collaborative Practice Agreement & Documentation Best Practices for activity ACPE UAN 0009-0000-24-012-L03-P, and 3 hours (0.3 CEUs) for Long Acting Injectables Hands-On LIVE Workshop ACPE UAN 0009-0000-24-013-L01-P. UConn will be award credits once learner attends the full 5 hours, successfully passes the injection assessment and submits their evaluation. Your CE credits will be uploaded to your CPE monitor profile within 24 hours of your submitting the evaluation.
Grant Funding
There is no grant funding for this activity.
Requirements for Successful Completion
To receive CE credit for this activity, the leaner must attend the full 5 hours of the LIVE workshop, pass the injection assessment, and submit their evaluation online.
To Receive the Certificate in Long Acting Injectables the learner must complete this live workshop (requirements described above, and the 3 online pre-requisites.
Faculty
Kristin Waters, PharmD, BCPS, BCPP,
Assistant Clinical Professor
UConn School of Pharmacy
Storrs, CT
Nathaniel Rickles, PharmD, PhD, BCPP, FAPhA
Professor of Pharmacy Practice
UConn School of Pharmacy
Storrs, CT
Sharon Spicer, BSRN
Director of Quality Assurance and Customer Success
Connecticut Pharmacy & Long Term Care
Wallingford, CT
Faculty Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Dr. Waters is a consultant with Janssen Pharmaceuticals. She will discuss all drugs without bias. All financial interests with ineligible companies (as noted) have been mitigated.
Dr. Rickles and Sharon Spicer have no relationships with ineligible companies.
Disclaimer
This activity may contain discussion of off label/unapproved use of drugs. The content and views presented in this educational program are those of the faculty and do not necessarily represent those of the University of Connecticut School of Pharmacy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Program Handouts-these are the handouts from January 2024 (there may be updates for the March 2026 workshop)
-Slides for Stigma, Barriers, and Outcomes for Patients Treated with LAIs
-Opening Minds Handout
-Slides for -Collaborative Practice Agreement & Documentation Best Practices
-NICE Form
-NICE Form Instructions
-Appointment Card Document
-Handouts for Medication Specific Administration Instructions
Additional Resources
-LAIA Appendix-please check all information to current package inserts
-Informed Consent-Abilify Maintena